Barbara Lung

FACC (Austria)

Papers

1

Total Citations

21

H-Index

1

About

Dr. Barbara Lung is a leading researcher in veterinary microbiology and antimicrobial drug discovery, with a focused expertise in bovine mastitis—a costly disease affecting dairy cattle worldwide. Her most cited work investigates the antimicrobial potential of plant-derived aldehydes against *Staphylococcus aureus*, the primary pathogen responsible for mastitis. In her landmark 2018 study, Dr. Lung demonstrated that gentisaldehyde and 2,3-dihydroxybenzaldehyde exhibit significant antimicrobial activity against bovine mastitis-associated *S. aureus*, offering a promising alternative to conventional antibiotics in the face of rising antimicrobial resistance. This work, which has garnered 21 citations, addresses a critical gap in veterinary medicine by identifying novel, naturally occurring compounds that could reduce economic losses in the dairy industry while combating the spread of resistant pathogens. Dr. Lung’s contributions are particularly timely, as the global dairy sector urgently seeks sustainable, non-antibiotic treatments for infectious diseases. Her research not only advances fundamental knowledge of plant-based antimicrobials but also provides practical, translational solutions for animal health and agricultural sustainability.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Gentisaldehyde and Its Derivative 2,3-Dihydroxybenzaldehyde Show Antimicrobial Activities Against Bovine Mastitis Staphylococcus aureus
21 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: FACC (Austria)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago